MedAvante Names Ropacki Head of Research and Development

Accomplished Clinical Scientist Will Accelerate Company’s Growth

Hamilton, NJ (February 22, 2017) — MedAvante, Inc., the leading global clinical data services company dedicated to maximizing signal detection in clinical trials, announced that Michael T. Ropacki, PhD, has been appointed Vice President, Research and Development to lead the company’s continued expansion of clinical science and signal detection capabilities.

Ian Neilson Joins MedAvante As Global IT Leader

Former Covance Executive Is Accomplished Technology Innovator

Hamilton, NJ (February 8, 2017) — MedAvante, Inc., the leading global clinical data services company dedicated to maximizing signal detection in clinical trials, announced that Ian C. Neilson has accepted the position of Senior Vice President, Global Information Technology to lead the company’s rapidly growing IT operations supporting clinical science and signal detection capabilities.

MedAvante Names Leader for Patient-Focused eSolutions

ePRO Expert Will Enhance Electronic Clinical Outcome Assessment Offerings

Hamilton, NJ (January 26, 2017) — MedAvante, Inc., the leader in technology-based clinical trial services for treatments of central nervous system (CNS) diseases, announced that Susan Vallow, RPh MBA MA, has assumed a new position as Vice President, Patient eSolutions, joining MedAvante from GSK where she was Senior Director and Head of Patient Focused Outcomes.

MedAvante Surpasses 630,000 Electronic Source (eSource) Clinical Trial Assessments

Extends Leadership Position in Electronic Clinical Outcome Assessments (eCOA)

Hamilton, NJ (November 15, 2016) — MedAvante, Inc., the leader in technology-based clinical trial services for central nervous system (CNS) diseases, announced significant advances in the deployment of the groundbreaking Virgil® Investigative Study Platform for global clinical trials as the source (eSource) data platform begins its third year in worldwide use.

Two Former Covance Senior Executives Join MedAvante Board of Directors

Hamilton, NJ (June 21, 2016) – MedAvante, Inc., the leader in technology-based clinical trial services for central nervous system (CNS) diseases, announced two new members of its Board of Directors: Richard F. Cimino, former Covance, Inc. EVP and Group President of Clinical Development and Commercialization Services, and Nigel Brown, former Corporate Vice President of Business Development and Strategy at Covance.